SARS-CoV-2, the causative agent of COVID-19, remains among the main causes of global
mortality. Although antigen/antibody-based immunoassays and neutralizing antibodies …

Toxoplasma gondii infection in the central nervous system commonly occurs among
immunodeficient patients. Its prevalence is high in countries with a high burden of HIV and …

During an epidemic or pandemic, the primary task is to rapidly develop precise diagnostic
approaches and effective therapeutics. Oligonucleotide aptamer-based pathogen detection …

The development of a colorimetric severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) detection assay with the WHO published ASSURED criteria is reported, in which the …

The rapid spread of SARS-CoV-2 infection throughout the world led to a global public health
and economic crisis triggering an urgent need for the development of low-cost vaccines …

Simultaneous detection of different biomarkers from a single specimen in a single test,
allowing more rapid, efficient, and low-cost analysis, is of great significance for accurate …

Single atom nanozymes (SAzymes) represent the state-of-the-art technology in
nanomaterial-based catalysis, which have attracted attentions in catalysis, cancer treatment …

Allergen detection methods support food labeling and quality assessment at the allergen
component level of allergen preparations used for allergy diagnosis and immunotherapy …

Centuries of scientific breakthroughs have brought us closer to understanding and
managing the spread of parasitic diseases. Despite ongoing technological advancements in …

The accurate detection of Human epidermal growth factor receptor-2 (HER2) as a critical
breast cancer biomarker can be essential for the early selection of therapeutic approaches …